top of page
All Peptides Sold on PeptideX Are for Research & Laboratory Use Only

Tirzepatide 2.5mg - 10mg

Price

£99.00

Tirzepatide Product Description

Product Name: Tirzepatide
Drug Class: Dual GIP and GLP-1 Receptor Agonist
Administration: Subcutaneous Injection (FDA-approved), Oral Formulations (Compounded, Not FDA-approved)
Brand Names: Mounjaro (for Type 2 Diabetes), Zepbound (for Weight Management)
 

Description:

Tirzepatide is an innovative, once-weekly injectable medication designed for the treatment of type 2 diabetes mellitus (T2DM) and weight management in adults. It is a dual incretin receptor agonist, targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism enhances glucose control, appetite suppression, and weight reduction more effectively than traditional GLP-1 agonists alone.

 

Mechanism of Action:

Tirzepatide works by:
✅ Stimulating insulin secretion in response to glucose levels
✅ Reducing glucagon production, lowering blood sugar levels
✅ Delaying gastric emptying, leading to reduced appetite and prolonged satiety
✅ Promoting weight loss through decreased food intake and increased energy expenditure

 

Indications:

Type 2 Diabetes Mellitus (T2DM): Improves blood sugar levels when combined with diet and exercise
Chronic Weight Management: Approved for obesity or overweight individuals with weight-related conditions such as hypertension or dyslipidemia

 

Key Benefits:

Superior Glycemic Control: Lowers A1C more effectively than traditional GLP-1 receptor agonists
Significant Weight Loss: Clinical trials show average reductions of 15-25% body weight
Cardiovascular Benefits: May reduce risks of heart-related complications in diabetic patients
Convenient Weekly Injection: Long-acting formulation enhances compliance

 

Side Effects:

Common: Nausea, vomiting, diarrhea, decreased appetite, constipation
Serious (Rare): Pancreatitis, thyroid tumors, kidney issues, hypoglycemia (when combined with insulin)

 

Precautions & Contraindications:

❌ Not recommended for individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
❌ Use with caution in patients with severe gastrointestinal diseases
❌ Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis

Dosage

Quantity

DISCLAIMER

All products listed and supplied by Peptidex are strictly for research purposes only. We neither advocate nor support the personal usage of these products.

Usage

Dosage & Administration (Injection Form):

💉 Starting Dose: 2.5 mg once weekly for 4 weeks
💉 Maintenance Doses: Gradual increase to 5 mg, 10 mg, or 15 mg weekly based on patient response
💉 Maximum Dose: 15 mg per week

(Oral formulations from compounding pharmacies have varying dosages, and their efficacy is not established.)

Ingredients:

  • Tirzepatide- 5mg
  • Filled with inert gas or in a vacuum

Appearance: White Crystalline Solid

Solvent: Water soluble: 2 ml

Solution Colour: Clear

​​​​​​​Tirzepatide Injection Sites

Tirzepatide Injection Sites

Tirzepatide is administered as a once-weekly subcutaneous (under the skin) injection. The recommended injection sites include:

Approved Injection Sites:

Abdomen – Preferred site, at least 2 inches away from the navel
Thighs – Either the front or outer thigh area
Upper Arm – The back of the upper arm (triceps area) (if administered by another person)

Injection Guidelines:

✔ Rotate injection sites weekly to prevent skin irritation or lipodystrophy
✔ Avoid injecting into bruised, tender, or scarred areas
✔ Do not inject into muscle (intramuscular) or veins (intravenous)
✔ Use a clean, dry area for each injection

How to Inject:

  • Wash hands and clean the injection site with an alcohol swab
  • Remove the cap from the prefilled pen
  • Pinch the skin gently and insert the needle at a 90-degree angle
  • Press and hold the injection button until the full dose is delivered
  • Dispose of the pen safely in a sharps container

Tirzepatide injections are designed for self-administration and should be taken on the same day each week for consistent results. Always follow your healthcare provider's guidance for proper use. 

bottom of page